Victor Penev, CEO and Founder of Edamam, dives into the promising world of 'food as medicine,' exploring how it’s finally gaining traction in healthcare. He discusses the impact of GLP-1 medications and generative AI in reshaping nutrition strategies. Penev highlights the growing demand for clean, sustainable food—especially among Gen Z—and envisions a future where AI provides personalized dietary recommendations. Funding opportunities and innovative business models are also on the horizon, marking a pivotal moment for nutritional science.
00:00
forum Ask episode
web_stories AI Snips
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
insights INSIGHT
GLP-1s and Food as Medicine
GLP-1 medications create a market opportunity for food as medicine.
People desire guidance on food choices before, during, and after taking GLP-1 drugs.
insights INSIGHT
Food as Medicine Business Model
The biggest challenge for food as medicine is the unclear business model.
It's uncertain who will pay: health plans, pharma, grocery stores, or consumers.
insights INSIGHT
Challenges in Food as Medicine Research
Conducting controlled trials for food as medicine interventions is challenging.
The food industry lacks the organization and funding of the pharmaceutical industry.
Get the Snipd Podcast app to discover more snips from this episode
This idea called “food as medicine” isn’t new. People have been talking for decades about how the foods we put in our body play a bigger role in preventative health and disease management than any drug or medication we could.
But it’s always been on the fringe. Partly because it’s difficult to do the studies that clinically prove that foods can be as effective as medications. And second, which is related, there hasn’t been much funding for this kind of work.
So, what’s changed? To answer that question, we sat down with Victor Penev, CEO & Founder of Edamam, a longtime member of the StartUp Health Community. Victor’s created what may be the world’s largest repository of food data. But he’s also a futurist with a keen eye on where the industry is heading.
In our conversation Penev explains how the uptake in GLP-1s and generative AI have come together in a fascinating way that opens up new opportunities in nutrition. Importantly, it may open up new funding sources and innovative business models.
On that note: StartUp Health has formally kicked off our Food as Medicine Health Moonshot Community, so if you or someone you know is a founder working in nutrition, someone with a passion to use food to make the world a healthier place, we’re accepting applications at StartUpHealth.com.
Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Showcase Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. Learn more and apply today.
Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.